MyFinsight
Home
Compare
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
$130,914K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net loss
Proceeds from sale of equity met...
Proceeds from issuance of long-t...
Others
Negative Cash Flow Breakdown
Deferred revenue
Gain on sale of equity method in...
Deposit liability
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
Net loss
193,654
Loss from discontinued operations
-2,832
Stock-based compensation
2,120
Non-cash lease expense
121
Depreciation
13
Change in fair value of convertible notes
1,315
Change in fair value long-term debt
-1,659
Change in fair value of revenue interest liability
-460
Change in fair value of contingent asset
116
Debt issuance costs expensed upon issuance of long-term debt recorded using the fair value option
-2,845
Gain on sale of equity method investment
85,380
Prepaid research and development
-134
Accounts receivable
-269
Prepaid assets, other current assets and other assets
4,427
Accounts payable
2,715
Accrued expenses and other current liabilities
-2,741
Deferred revenue
-93,525
Deposit liability
57,120
Operating lease liability
-123
Net cash used in operating activities
-37,925
Transfer fees related to sale of equity method investment
336
Proceeds from sale of equity method investment
100,000
Net cash provided by investing activities
99,664
Proceeds from issuance of convertible preferred stock
25,000
Issuance costs of convertible preferred stock
-208
Payment of initial public offering costs
1,785
Proceeds from issuance of long-term debt and revenue interest liability
48,185
Issuance costs of long-term debt and revenue interest liability
2,845
Proceeds from issuance of warrants
815
Issuance costs of warrants
48
Proceeds from exercise of stock options
61
Net cash provided by financing activities
69,175
Net increase (decrease) in cash and cash equivalents
130,914
Cash and cash equivalents beginning of period
41,890
Cash and cash equivalents end of period
172,804
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from sale of
equity method...
$100,000K
Proceeds from issuance of
long-term debt and revenue...
$48,185K
Proceeds from issuance of
convertible preferred stock
$25,000K
Proceeds from issuance of
warrants
$815K
Proceeds from exercise of
stock options
$61K
Net cash provided by
investing activities
$99,664K
Net cash provided by
financing activities
$69,175K
Canceled cashflow
$336K
Canceled cashflow
$4,886K
Net increase
(decrease) in cash and cash...
$130,914K
Canceled cashflow
$37,925K
Transfer fees related to
sale of equity method...
$336K
Issuance costs of
long-term debt and revenue...
$2,845K
Payment of initial
public offering costs
$1,785K
Issuance costs of
convertible preferred stock
-$208K
Issuance costs of
warrants
$48K
Net loss
$193,654K
Debt issuance costs
expensed upon issuance of...
-$2,845K
Loss from
discontinued operations
-$2,832K
Accounts payable
$2,715K
Stock-based compensation
$2,120K
Change in fair value
long-term debt
-$1,659K
Change in fair value of
revenue interest...
-$460K
Accounts receivable
-$269K
Prepaid research and
development
-$134K
Non-cash lease expense
$121K
Depreciation
$13K
Net cash used in
operating activities
-$37,925K
Canceled cashflow
$206,822K
Deferred revenue
-$93,525K
Gain on sale of equity
method investment
$85,380K
Deposit liability
$57,120K
Prepaid assets, other
current assets and other...
$4,427K
Accrued expenses and
other current...
-$2,741K
Change in fair value of
convertible notes
$1,315K
Operating lease liability
-$123K
Change in fair value of
contingent asset
$116K
Buy us a coffee
Apnimed, Inc. (APMD)
Apnimed, Inc. (APMD)